ICC Rejects Claims That Enzymotec's IPO Breached Deal
Israeli biotechnology and health products company Enzymotec Ltd. on Tuesday announced an International Chamber of Commerce award in its favor, saying a tribunal rejected accusations by a Swedish company that aspects of...To view the full article, register now.
Already a subscriber? Click here to view full article